Selective gene transfer into neurons via Na,K-ATPase β1. Targeting gene transfer with monoclonal antibody and adenovirus vector

Journal of Gene Medicine

Volumn 10, Issue 6, 2008, Pages 597-609

  Ishii, Keiji ^a,b   Nakamura, Kiminori ^a   Kawaguchi, Satoshi ^b   Li, Rong ^a   Hirai, Sachie ^a   Sakuragi, Naoya ^a   Wada, Takuro ^b   Kato, Kazunori ^a   Yamashita, Toshihiko ^b   Hamada, Hirofumi ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenovirus vector; Gene therapy; Na,K ATPase 1; Neuron; Targeting

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) BETA1; ADENOVIRUS VECTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6E3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; GENE TARGETING; GENE TRANSFER; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MOLECULAR CLONING; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; SENSITIVITY AND SPECIFICITY; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, MONOCLONAL; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HYBRIDOMAS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MICE; NERVOUS SYSTEM DISEASES; NEURONS; PC12 CELLS; RATS; SODIUM-POTASSIUM-EXCHANGING ATPASE; SPINAL CORD;

ADENOVIRIDAE; MUS; RATTUS;

EID: 46649105675     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1164     Document Type: Article

References (37)

1. Fleischer A, Ghadiri A, Dessauge F, et al. Modulating apoptosis as a target for effective therapy. Mol Immunol 2006; 43: 1065-1079.
2. Kennedy PG. Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders. Brain 1997; 120: 1245-1259.
3. Suwelack D, Hurtado-Lorenzo A, Millan E, et al. Neuronal expression of the transcription factor Glil using the T alpha1 alpha-tubulin promoter is neuroprotective in an experimental model of Parkinson's disease. Gene Ther 2004; 11: 1742-1752.
4. Tuszynski MH, Hoi-Sang U, Alksne J, et al. Growth factor gene therapy for Alzheimer's disease. Neurosurg Focus 2002; 13: e5.
5. Hendriks WT, Ruitenberg MJ, Blits B, Boer GJ, Verhaagen J. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog Brain Res 2004; 146: 451-476.
6. Kurozumi K, Nakamura K, Tamiya T, et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005; 11: 96-104.
7. Klein SM, Behrstock S, McHugh J, et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 2005; 16: 509-521.
8. Beck C, Uramoto H, Boren J, Akyurek LM. Tissue-specific targeting for cardiovascular gene transfer. Potential vectors and future challenges. Curr Gene Ther 2004; 4: 457-467.
9. Kojima A, Tator CH. Intrathecal administration of epidermal growth factor and fibroblast growth factor 2 promotes ependymal proliferation and functional recovery after spinal cord injury in adult rats. J Neurotrauma 2002; 19: 223-238.
10. Klimaschewski L, Nindl W, Feurle J, Kavakebi P, Kostron H. Basic fibroblast growth factor isoforms promote axonal elongation and branching of adult sensory neurons in vitro. Neuroscience 2004; 126: 347-353.
11. Ye J, Cao, L, Cui R, et al. The effects of ciliary neurotrophic factor on neurological function and glial activity following contusive spinal cord injury in the rats. Brain Res 2004; 997: 30-39.
12. Steffens S, Sandquist A, Frank S, et al. A neuroblastoma-selective suicide gene therapy approach using the tyrosine hydroxylase promoter. Pediatr Res 2004; 56: 268-277.
13. Huang D, Desbois A, Hou ST. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons. Gene Ther 2005; 12: 1369-1376.
14. Yano L, Shimura M, Taniguchi M, et al. Improved gene transfer to neuroblastoma cells by a monoclonal antibody targeting RET, a receptor tyrosine kinase. Hum Gene Ther 2000; 11: 995-1004.
15. Gwag BJ, Kim EY, Ryu BR, et al. A neuron-specific gene transfer by a recombinant defective Sindbis virus. Brain Res Mol Brain Res 1998; 63: 53-61.
16. Volpers C, Thirion C, Biermann V, et al. Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin γ-binding domain in the capsid. J Virol 2003; 77: 2093-2104.
17. Roelvink PW, Mi Lee G, Einfeld DA, Kovesdi I, Wickham TJ. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 1999; 286: 1568-1571.
18. Kirby I, Davison E, Beavil AJ, et al. Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR. J Virol 1999; 73: 9508-9514.
19. Mizuguchi H, Koizumi N, Hosono T, et al. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther 2004; 9: 769-776.
20. Tanaka T, Huang J, Hirai S, et al. Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors. Clin Cancer Res 2006; 12: 3803-3813.
21. Nakamura T, Sato K, Hamada H. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors. Hum Gene Ther 2002; 13: 613-626.
22. Nyberg-Hoffman C, Shabram P, Li W, Giroux D, Aguilar-Cordova E. Sensitivity and reproducibility in adenoviral infectious titer determination. Nat Med 1997; 3: 808-811.
23. Zhang WW, Koch PE, Roth JA. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques 1995; 18: 444-447.
24. Uchida H, Shinoura N, Kitayama J, Watanabe T, Nagawa H, Hamada H. 5-Fluouracil efficiently enhanced apoptosis induced by adenovirus-mediated transfer of caspase-8 in DLD-1 colon cancer cells. J Gene Med 2003; 5: 287-299.
25. Woo AL, James PF, Lingrel JB. Characterization of the fourth alpha isoform of the Na, K-ATPase. J Membr Biol 1999; 169: 39-44.
26. Kuster B, Shainskaya A, Pu HX, et al. A new variant of the gamma subunit of renal Na, K-ATPase. Identification by mass spectrometry, antibody binding, and expression in cultured cells. J Biol Chem 2000; 16: 18441-18446.
27. Therien AG, Karlish SJ, Blostein R. Expression and functional role of the gamma subunit of the Na, K-ATPase in mammalian cells. J Biol Chem 1999; 274: 12252-12256.
28. Arystarkhova E, Wetzel RK, Sweadner KJ. Distribution and oligomeric association of splice forms of Na(+)-K(+)-ATPase regulatory gamma-subunit in rat kidney. Am J Physiol Renal Physiol 2002; 282: F393-F407.
29. Mercer RW, Biemesderfer D, Bliss DP Jr, Collins JH, Forbush B III. Molecular cloning and immunological characterization of the gamma polypeptide, a small protein associated with the Na, K-ATPase. J Cell Biol 1993; 121: 579-586.
30. 2+ exchanger. J Neurosci 1996; 16: 545-552.
31. Geering K. The functional role of beta subunits in oligomeric P-type ATPases. J Bioenerg Biomembr 2001; 33: 425-438.
32. +, K(+)-ATPase alpha- and beta-subunit isoforms within the rat central nervous system. Proc Natl Acad Sci USA 1991; 88: 7425-7429.
33. Cameron R, Klein L, Shyjan AW, Rakic P, Levenson R. Neurons and astroglia express distinct subsets of Na, K-ATPase alpha and beta subunits. Brain Res Mol Brain Res 1994; 21: 333-343.
34. Peng L, Martin-Vasallo P, Sweadner KJ. Isoforms of Na, K-ATPase alpha and beta subunits in the rat cerebellum and in granule cell cultures. J Neurosci 1997; 17: 3488-3502.
35. Peng L, Arystarkhova E, Sweadner KJ. Plasticity of Na, K-ATPase isoform expression in cultures of flat astrocytes: species differences in gene expression. Glia 1998; 24: 257-271.
36. Martin-Vasallo P. Oligodendrocytes in brain and optic nerve express the beta3 subunit isoform of Na, K-ATPase. Glia 2000; 31: 206-218.
37. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 1998; 275: F633-F650.